US Archives - Page 110 of 173 - European Medical Journal

Nintedanib May Slow Lung Function Decline in SSc-ILD

A recent analysis of the SENSCIS and SENSCIS-ON trials has demonstrated that nintedanib effectively slows the decline in forced vital capacity (FVC) among patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).

Hepatitis C Diagnostic Advances: New Review

A newly published review highlights the evolution of Hepatitis C Virus (HCV) diagnostics, detailing key technological breakthroughs that have improved detection and management.

Cognitive Decline Linked to Fewer Doctor Visits

Critical gaps in outpatient ambulatory care utilization among older adults with dementia and mild cognitive impairment (MCI) have been revealed in a new study.

The Adrenal CT Controversy: Are We Over-Scanning?

The widespread overuse of adrenal CT scans, revealing that more than half of these imaging studies are performed unnecessarily, has been investigated in a new study.

Daily Almonds Boost Gut Microbes and Reduce Inflammation

Incorporating almonds into the diet can significantly improve gut microbiota composition, enhance metabolic health, and reduce inflammation, according to new research.

Fungal Infection After TB Treatment Commonly Seen

A new systematic review highlights a significant but often overlooked complication in tuberculosis (TB) survivors—chronic pulmonary aspergillosis (CPA), a progressive fungal disease that can severely impact respiratory health.

Medical Cannabis Linked to Hypermobility-Associated Chronic Pain Relief

A recent study conducted with the UK Medical Cannabis Registry evaluated the impact of cannabis-based medicinal products (CBMPs) on patients suffering from chronic pain due to hypermobility spectrum disorder (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS).

Online Revolution for Nail-Biting Reversal and Behavior Therapy

Body-focused repetitive behaviors (BFRBs), including skin-picking, hair-pulling, and nail-biting, significantly impact quality of life, yet access to effective treatments remains a challenge.

Does Dual Antiplatelet Therapy Improve Stroke Outcomes?

A new systematic review and meta-analysis has assessed whether dual antiplatelet therapy (DAPT) offers significant benefits over single antiplatelet therapy (SAPT) for patients with minor stroke following thrombolysis.

Osimertinib's Role in Detecting Residual Lung Cancer

A new post hoc analysis of the ADAURA trial highlights the role of osimertinib in detecting molecular residual disease (MRD) in resected EGFR-mutated stage IB–IIIA non-small-cell lung cancer (NSCLC).